We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Systemic Therapy for Non-Melanoma Skin Cancers: Latest Advances

    Purpose of Review

    This review provides an update on approved and emerging systemic therapies in the treatment of locally advanced or metastatic...

    Spencer Lessans, Katie A. O’Connell, Jennifer Choe in Current Oncology Reports
    Article Open access 02 July 2024
  2. Non-Surgical Therapeutic Strategies for Non-Melanoma Skin Cancers

    Non-melanoma skin cancer (NMSC) is a globally prevalent skin disease, with basal cell carcinoma and squamous cell carcinoma accounting for 99% of...

    Qingyu Zeng, Chengqian Chen, ... **uli Wang in Current Treatment Options in Oncology
    Article 14 December 2023
  3. Incidence of melanoma and non-melanoma skin cancer in patients with celiac disease: a systematic review and meta-analysis

    Background

    There is conflicting observational evidence regarding the association between skin cancer and celiac disease (CD). The purpose of this...

    Patrick J. Kim, Rafael Paolo Lansang, ... Mohannad Abu-Hilal in European Journal of Dermatology
    Article 01 September 2023
  4. The accuracy of artificial intelligence used for non-melanoma skin cancer diagnoses: a meta-analysis

    Background

    With rising incidence of skin cancer and relatively increased mortality rates, an improved diagnosis of such a potentially fatal disease is...

    Kuang Ming Kuo, Paul C. Talley, Chao-Sheng Chang in BMC Medical Informatics and Decision Making
    Article Open access 28 July 2023
  5. Neoadjuvant Immunotherapy in Non-melanoma Skin Cancers of the Head and Neck

    Neoadjuvant immunotherapy will change the standard of care for advanced resectable cutaneous squamous cell carcinoma (cSCC) and possibly other...

    Rami Ezzibdeh, Mohamed Diop, Vasu Divi in Current Treatment Options in Oncology
    Article 25 June 2024
  6. Non-Melanoma Skin Cancer Treatment Updates in the Elderly

    Purpose of Review

    This review article highlights recent advancements in the treatment of non-melanoma skin cancer (NMSC), focusing on efficacy and...

    Emma L. Myers, Rachel C. Blasiak in Current Geriatrics Reports
    Article 21 May 2024
  7. Access to systemic treatment of non-melanoma skin cancer in Spain: a survey analysis

    Background

    Novel and highly effective drugs for non-melanoma skin cancer (NMSC) improve patient outcomes, but their high cost strains healthcare...

    Pablo Cerezuela-Fuentes, Maria Gonzalez-Cao, ... Susana Puig in Clinical and Translational Oncology
    Article 01 July 2024
  8. Analysis of Prevalence, Socioeconomic and Disease Trends of Non-Melanoma Skin Cancer in New Zealand from 2008 to 2022

    Background

    Skin cancer shows geographic and ethnic variation. New Zealand—with a predominantly fair-skinned populations, high UV indices and outdoor...

    Sharad Paul, Yipan Chen, Mahsa Mohaghegh in Journal of Epidemiology and Global Health
    Article Open access 06 June 2024
  9. Neurological autoimmunity in melanoma patients: a comparison between those exposed and non-exposed to immune checkpoint inhibitors

    Background

    The clinical spectrum of melanoma-associated neurological autoimmunity, whether melanoma-associated paraneoplastic neurological syndromes...

    Andreu Vilaseca, Antonio Farina, ... Bastien Joubert in Journal of Neurology
    Article 11 March 2024
  10. Neoadjuvant Photodynamic Therapy: An Updated Therapeutic Approach for Non-Melanoma Skin Cancers

    Non-melanoma skin cancers (NMSCs) are the most common malignancy and surgical excision is considered treatment of choice for the majority of cases....

    Jia Yan, Bo Wang, ... **uli Wang in Current Treatment Options in Oncology
    Article 18 May 2024
  11. Clinical Application of Artificial Intelligence for Non-melanoma Skin Cancer

    The development and implementation of artificial intelligence is beginning to impact the care of dermatology patients. Although the clinical...

    Katherine Sanchez, Kanika Kamal, ... Arash Mostaghimi in Current Treatment Options in Oncology
    Article 14 March 2023
  12. Topical Treatment of Melanoma In Situ, Lentigo Maligna, and Lentigo Maligna Melanoma with Imiquimod Cream: A Systematic Review of the Literature

    Introduction

    The classical management of melanoma is surgery, but this can be challenging because of several factors, such as age, body area, lesion...

    Silvia Vaienti, Paolo Calzari, Gianluca Nazzaro in Dermatology and Therapy
    Article Open access 24 August 2023
  13. Sleep and quality of life in kidney transplant recipients with and without non-melanoma skin cancer: a comparative study

    Non-melanoma skin cancer (NMSC) is prevalent in kidney transplant recipients (KTR), related to the immunosuppressive effects of anti-rejection...

    Ellen M. S. Xerfan, Gabriela M. Leandro, ... Jane Tomimori in Archives of Dermatological Research
    Article 18 December 2023
  14. SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry

    Background

    The Spanish Melanoma Group (GEM) developed a national registry of patients with melanoma infected by SARS-CoV-2 (“GRAVID”).

    ...
    Maria Gonzalez-Cao, Teresa Puertolas, ... Alfonso Berrocal in Clinical and Translational Oncology
    Article 24 December 2022
  15. Validation of the Melanoma Institute of Australia’s Sentinel Lymph Node Biopsy Risk Prediction Tool for Cutaneous Melanoma

    Background

    For patients with cutaneous melanoma, sentinel lymph node biopsy (SLNB) is used to stage regional lymph nodes pathologically and inform...

    Sainiteesh Maddineni, Matthew P. Dizon, ... Susan M. Swetter in Annals of Surgical Oncology
    Article 12 January 2024
  16. Prognostic and Predictive Significance of Ki67 in Primary Non-metastatic or Recurrent Acral Melanoma: Evidence from a Multicenter Retrospective Study

    Background

    The purpose of this work was to investigate the prognostic significance of Ki67 in acral melanoma (AM).

    Patients and Methods ...
    Chengcai Liang, Dandan Li, ... Yao Liang in Annals of Surgical Oncology
    Article 30 April 2024
  17. Oral nicotinamide for non-melanoma skin cancers: A review

    There has been much interest in the role of oral nicotinamide supplementation in reducing the incidence of non-melanoma skin cancers. This article...

    Samantha Vicki Hunt, Aaron Jamison, Raman Malhotra in Eye
    Article 28 March 2022
  18. The palliative role of lasers in the treatment of melanoma

    Melanoma, accounting for a significant proportion of skin cancer-related deaths, has variable survival outcomes based on the stage at diagnosis and...

    Yanci A. Algarin, Anika Pulumati, ... Keyvan Nouri in Archives of Dermatological Research
    Article Open access 25 May 2024
  19. Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial)

    Purpose

    Adjuvant treatment with immune checkpoint inhibitors like PD1-antibodies (ICI) ± CTLA4-antibodies (cICI) or targeted therapy with BRAF/MEK...

    Katharina C. Kähler, S. Hüning, ... C. Blome in Journal of Cancer Research and Clinical Oncology
    Article Open access 05 July 2023
  20. Surgery in the Era of Immunotherapy for Advanced Head and Neck Non-melanoma Skin Cancer

    Purpose of Review

    Surgery remains the mainstay of treatment for non-melanoma skin cancer (NMSC). Immunotherapy (IO) has emerged as an alternative...

    Alice Lin, Cecelia E. Schmalbach in Current Oncology Reports
    Article 03 April 2023
Did you find what you were looking for? Share feedback.